IP Library › Granted Patent US 12,195,753
Granted Patent B2
US 12,195,753 · App. 17/941,835 · Granted Jan 14, 2025

Nucleic acid and other compositions and methods for the modulation of cell membranes

Inventors: Aleksei Aksimentiev (Urbana, IL); Ulrich F. Keyser (Cambridge, GB)
Assignees: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS; CAMBRIDGE ENTERPRISE LIMITED
C12N5/0006A61K9/5146A61K31/711A61K31/713C12N15/11C12N15/111C12N2310/3515
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,195,753
App. No.
17/941,835
Granted
Jan 14, 2025
Kind
B2
Abstract

The present invention provides compositions and methods for transferring phospholipids and other molecules between the leaflets of a cell membrane. The compositions comprise at least one nucleic acid or compound having a hydrophilic region, where the composition is able to form a nanostructure that forms a toroidal pore in a lipid membrane. The nucleic acid or hydrophilic region-containing compound further contains an attached molecule capable of inserting the nanostructure into the lipid membrane. The invention also provides methods for scrambling lipids and other molecules in a cell membrane, which can be used to alter the function of a selected cell or to facilitate the death of the cell. The scrambling activity of synthetic scramblases described herein outperforms previously known enzymatically active DNA nanostructures and naturally occurring scramblases, in some cases by several orders of magnitude.

Claims (22)

1. A composition comprising:

one or more nucleic acids having at least one interconnected nucleic acid duplex, wherein the one or more nucleic acids form a nanostructure comprising one or more hydrophilic regions,

one or more hydrophobic molecules comprising cholesterol, α-tocopherol, stearate, palmitate, or derivatives thereof, wherein the one or more hydrophobic molecules extend from a membrane-spanning region of the nanostructure; and

an aliphatic linker having between 1-16 carbon atoms attached to each of the one or more hydrophobic molecules, wherein each linker covalently attaches one of the one or more hydrophobic molecules to the membrane-spanning region of the nanostructure, wherein the nanostructure is able to be inserted into a lipid membrane and form a toroidal pore, wherein the membrane-spanning region is located between an inner leaflet and outer leaflet of the lipid membrane, and

wherein the one or more hydrophobic molecules are able to be embedded within the lipid membrane between the inner leaflet and outer leaflet of the lipid membrane and insert the nanostructure into the lipid membrane to form the toroidal pore.

2. The composition of claim 1 , wherein at least one of the nucleic acids comprises a polynucleotide sequence having at least 90% sequence identity to any of SEQ ID NO: 1-8.

3. The composition of claim 1 , wherein the composition comprises a plurality of nucleic acids which form the nanostructure, which comprises four interconnected nucleic acid duplexes, wherein at least a portion of the one or more hydrophobic molecules are attached to at least two of the nucleic acids.

4. The composition of claim 1 , wherein the nanostructure comprises an assembly of eight nucleic acids having at least one interconnected nucleic acid duplex, wherein the assembly of eight nucleic acids comprises: a first nucleic acid having at least 90% sequence identity to SEQ ID NO:1, a second nucleic acid having at least 90% sequence identity to SEQ ID NO:2, a third nucleic acid having at least 90% sequence identity to SEQ ID NO:3, a fourth nucleic acid having at least 90% sequence identity to SEQ ID NO:4, a fifth nucleic acid having at least 90% sequence identity to SEQ ID NO:5, a sixth nucleic acid having at least 90% sequence identity to SEQ ID NO:6, a seventh nucleic acid having at least 90% sequence identity to SEQ ID NO:7, and an eighth nucleic acid having at least 90% sequence identity to SEQ ID NO:8, and

wherein cholesterol is attached through the liker to the nucleic acids which correspond to SEQ ID NO:2 and SEQ ID NO:4.

5. The composition of claim 1 , wherein the linker comprises triethylene glycol (TEG), diethylene glycol (DEG), ethylene glycol (MEG), or polyethylene glycol (PEG).

6. The composition of claim 1 , wherein the one or more hydrophobic molecules have the structure:

7. The composition of claim 1 , wherein the composition further comprises a tag capable of allowing the composition to be detected once administered to a cell or tissue.

8. The composition of claim 7 , wherein the tag is a dye, fluorescent marker, isotopically labeled molecule, or radioactive tag.

9. The composition of claim 7 , wherein the tag is Cy3.

10. The composition of claim 1 , wherein the composition further comprises an activation mechanism able to cause a conformal change in the composition structure when exposed to selected stimuli, wherein said conformal change activates the nanostructure to be inserted into the lipid membrane and to form the toroidal pore.

11. The composition of claim 10 , wherein the activating mechanism comprises an azobenzene molecule attached to the composition and the stimuli comprises ultraviolet light.

12. The composition of claim 10 , wherein the activating mechanism comprises one or more molecules attached to the composition, wherein the one or more molecules are able to undergo conformational changes in response to a change in pH, and the stimuli comprises a local decrease in pH.

13. The composition of claim 1 , wherein at least one of the nucleic acids comprises a polynucleotide sequence having at least 95% sequence identity to any of SEQ ID NO: 1-8.

14. The composition of claim 1 , wherein at least one of the nucleic acids comprises a polynucleotide sequence having the sequence of any of SEQ ID NO: 1-8.

15. The composition of claim 1 , wherein the one or more nucleic acids are selected from the group consisting of: deoxyribonucleic acid (DNA), ribonucleic acid (RNA), locked nucleic acid (LNA), peptide nucleic acid (PNA), glycol nucleic acid (GNA), threose nucleic acid (TNA), phosphorodiamidate morpholino oligomers (PMO), and combinations thereof.

16. The composition of claim 1 , wherein the one or more nucleic acids are DNA, RNA, or combinations thereof.

17. The composition of claim 1 , wherein the composition further comprises a cell-specific anchor able to cause the composition to bind to a receptor of a specified cell type, or able to cause the specified cell type to partially absorb the composition.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2022
From: AKSIMENTIEV, ALEKSEI
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 061093/0195 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2022
From: KEYSER, ULRICH F.
To: CAMBRIDGE ENTERPRISE LIMITED
Reel/Frame 061093/0758 →
Continuity (3)
Division 16179214 · Nov 2, 2018
Provisional Application 62580553 · Nov 2, 2017
Related Publication 20230109020A1 · Apr 6, 2023
References Cited (77)
US 11441118B2 · Aksimentiev · 2022 [cited by examiner]
US 20190127682A1 · Aksimentiev et al. · 2019 [cited by applicant]
EP 2695949A1 · 2014 [cited by applicant]
WO WO9412206A1 · 1994 [cited by applicant]
Abdul et al., “Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: Implications for Alzhei… [cited by applicant]
Andersen, “Rattle: A “velocity” version of the shake algorithm for molecular dynamics calculations”, [cited by applicant]
Bansal et al., “Magainin, isolated from Xenopus laevis, induced Apoptosis in Human Cervical Carcinoma Cells”, [cited by applicant]
Batcho et al., “Optimized particle-mesh Ewald/multiple-time step integration for molecular dynamics simulations”, [cited by applicant]
Bevers et al., “Transmembrane phospholipid distribution in blood cells: control mechanisms and pathophysiological significance”, [cited by applicant]
Böckmann et al., “Effect of Sodium Chloride on a Lipid Bilayer”, [cited by applicant]
Boon et al., “Facilitated Phosphatidylserine (PS) Flip-Flop and Thrombin Activation Using A Synthetic PS Scramblase”, [cited by applicant]
Bretscher, “Asymmetrical Lipid Bilayer Structure for Biological Membranes”, [cited by applicant]
Burns et al., “A biomimetic DNA-based channel for the ligand-controlled transport of charged molecular cargo across a biological membrane”, [cited by applicant]
Burns et al., “Lipid-Bilayer-Spanning DNA Nanopores with a Bifunctional Porphyrin Anchor”, [cited by applicant]
Burns et al., “Self-Assembled DNA Nanopores That Span Lipid Bilayers”, [cited by applicant]
Castegna et al., “Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease”, [cited by applicant]
Comer et al., “Predicting the DNA Sequence Dependence of Nanopore Ion Current Using Atomic-Resolution Brownian Dynamics”, [cited by applicant]
De Vries et al., “Molecular Dynamics Simulation of the Spontaneous Formation of a Small DPPC Vesicle in Water in Atomistic Detail”, [cited by applicant]
Devaux et al., “How lipid flippases can modulate membrane structure”, [cited by applicant]
Douglas et al., “Rapid prototyping of 3D DNA-origami shapes with caDNAno”, [cited by applicant]
Fattal et al., “Pore-Forming Peptides Induce Rapid Phospholipid Flip-Flop in Membranes”, [cited by applicant]
Feller et al, “Constant pressure molecular dynamics simulation: The Langevin piston method”, [cited by applicant]
Fouquet, “Quick Guide to STED Sample Preparation”, [cited by applicant]
Göpfrich et al., “DNA-Tile Structures Induce lonic Currents through Lipid Membranes”, [cited by applicant]
Göpfrich et al., “Ion Channels Made from a Single Membrane-Spanning DNA Duplex”, [cited by applicant]
Göpfrich et al., “Large-Conductance Transmembrane Porin Made from DNA Origami”, [cited by applicant]
Goren et al., “Constitutive phospholipid scramblase activity of a G protein-coupled receptor”, [cited by applicant]
Gummadi et al., “Transbilayer movement of dipalmitoylphosphatidylcholine in proteoliposomes reconstituted from detergent extracts of endoplasmic reticulum”, [cited by applicant]
Gurtovenko et al., “Chemically Induced Phospholipid Translocation Across Biological Membranes”, [cited by applicant]
Gurtovenko et al., “Molecular Mechanism for Lipid Flip-Flops”, [cited by applicant]
Hoover, “Canonical dynamics: Equilibrium phase-space distributions”, [cited by applicant]
Khalid et al., “, DNA and lipid bilayers: self-assembly and insertion”, [cited by applicant]
Krishnan et al., “Molecular transport through large-diameter DNA nanopores”, [cited by applicant]
Kucerka et al., “Structure of Fully Hydrated Fluid Phase Lipid Bilayers with Monounsaturated Chains”, [cited by applicant]
Langecker et al., “Synthetic Lipid Membrane Channels Formed by Designed DNA Nanostructures”, [cited by applicant]
Leontiadou et al., “Antimicrobial Peptides in Action”, [cited by applicant]
Li et al., “Confocal Imaging to Quantify Passive Transport across Biomimetic Lipid Membranes”, [cited by applicant]
Li et al., “Ionic Conductivity, Structural Deformation, and Programmable Anisotropy of DNA Origami in Electric Field”, [cited by applicant]
Mackerell et al., All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of a. [cited by applicant]
Maffeo et al., “De novo reconstruction of DNA origami structures through atomistic molecular dynamics simulation”, [cited by applicant]
Malvezzi et al., “Ca [cited by applicant]
Martyna et al., “Constant pressure molecular dynamics algorithms”, [cited by applicant]
Matsuzaki et al., “An Antimicrobial Peptide, Magainin 2, Induced Rapid Flip-Flop of Phospholipids Coupled with Pore Formation and Peptide Translocation”, [cited by applicant]
McIntyre et al., “Fluorescence assay for phospholipid membrane asymmetry”, [cited by applicant]
Menon et al., “Opsin is a phospholipid flippase”, [cited by applicant]
Miyamoto et al., “Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models”, [cited by applicant]
Miyazaki et al., “Interaction of Antimicrobial Peptide Magainin 2 with Gangliosides as a Target for Human Cell Binding”, [cited by applicant]
Morra et al., “Mechanisms of Lipid Scrambling by the G Protein-Coupled Receptor Opsin”, [cited by applicant]
Nakano et al., “Flip-Flop of Phospholipids in Vesicles: Kinetic Analysis with Time-Resolved Small-Angle Neutron Scattering”, [cited by applicant]
Nakao et al., “Membrane-Spanning Sequences in Endoplasmic Reticulum Proteins Promote Phospholipid Flip-Flop”, [cited by applicant]
Nishioka et al., “A Photon-Fueled DNA Nanodevice that Contains Two Different Photoswitches”, [cited by applicant]
Nosé, “A unified formulation of the constant temperature molecular dynamics methods”, [cited by applicant]
Phillips et al., “Scalable molecular dynamics with NAMD”, [cited by applicant]
Pomorski et al., “Lipid somersaults: Uncovering the mechanisms of protein- mediated lipid flipping”, [cited by applicant]
Pomorski et al., “Tracking down lipid flippases and their biological functions”, [cited by applicant]
Ravichandran et al., “Engulfment of apoptotic cells: signals for a good meal”, [cited by applicant]
Sahu et al., “Phospholipid scramblases: An overview”, [cited by applicant]
Schlosser et al., “Biologically Inspired Synthetic Enzymes Made from DNA”, [cited by applicant]
Seifert et al., “Bilayer-Spanning DNA Nanopores with Voltage-Switching between Open and Closed State”, [cited by applicant]
Shaw et al., “Anton 2: Raising the Bar for Performance and Programmability in a Special-Purpose Molecular Dynamics Supercomputer,” [cited by applicant]
Silverman, “Catalytic DNA: Scope, Applications, and Biochemistry of Deoxyribozymes”, [cited by applicant]
Siu et al., “Biomolecular simulations of membranes: Physical properties from different force fields”, [cited by applicant]
Skeel et al., “Correcting Mesh-Based Force Calculations to Conserve Both Energy and Momentum in Molecular Dynamics Simulations”, [cited by applicant]
Vallabhapurapu et al., “Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium”, [cited by applicant]
Vanommeslaeghe et al., “Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typing”, [cited by applicant]
Venkatesan et al., “Lipid bilayer coated Al [cited by applicant]
Wang et al., “Facile Synthesis of Tetrafluorotyrosine and Its Application in pH Triggered Membrane Lysis”, [cited by applicant]
Williamson et al., “Continuous Analysis of the Mechanism of Activated Transbilayer Lipid Movement in Platelets”, [cited by applicant]
Yang et al., “Photo-Controllable DNA Origami Nanostructures Assembling into Predesigned Multiorientational Patterns”, [cited by applicant]
Yoo et al., “Improved Parameterization of Amine—Carboxylate and Amine—Phosphate Interactions for Molecular Dynamics Simulations Using the CHARMM and AMBER Force Fields”, [cited by applicant]
Yoo et al., “In situ structure and dynamics of DNA origami determined through molecular dynamics simulations”, [cited by applicant]
Yoo et al., “Improved Parametrization of Li [cited by applicant]
Yoo et al., “Molecular Dynamics of Membrane-Spanning DNA Channels: Conductance Mechanism, Electro-Osmotic Transport, and Mechanical Gating”, [cited by applicant]
Yu et al., “Identification of a lipid scrambling domain in ANO6/TMEM16F”, Emory University School of Medicine (2015). [cited by applicant]
Zachowski, “Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement”, [cited by applicant]
Zwaal et al., “Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids”, [cited by applicant]
U.S. Appl. No. 16/179,214, filed Nov. 2, 2018. [cited by applicant]